Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT03625557
Eligibility Criteria:
General Inclusion Criteria:
* Adults (≥ 18 years old) with a diagnosis of Stage 3 or Stage 4 cancer (non-hematologic malignancy). Patients with advanced cancers not typically staged 1-4 (such as extensive stage small lung cancer) may be enrolled.
* Results from Guardant360® test
* Patient has previously provided contact information (either email or phone) to Guardant Health.
* Able and wiling to complete the informed consent process.
* Willingness to consent to the release of medical records.
* Willingness to provide Medical Records Release
General Exclusion Criteria:
* Unwilling or unable to provide written informed consent.
* Unable to understand English.
* Diagnosis of NSCLC
* Guardant 360® test results released to the patient's physician no less than 14 days and no greater than 60 days prior to initial patient contact.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03625557
Study Brief:
Protocol Section:
NCT03625557